Leticia Monjas

Leticia Monjas

Auto-generated profile, based on publicly available information

Leticia Monjas

Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MFMaría Isabel Fernández-Bachiller
María Isabel Fernández-Bachiller
CPConcepción Pérez
Concepción Pérez
LMLeticia Monjas
Leticia Monjas
JRJörg Rademann
Jörg Rademann
MRMaría Isabel Rodríguez-Franco
María Isabel Rodríguez-Franco

21 December 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MCMourad Chioua
Mourad Chioua
DSDavid Sucunza
David Sucunza
ESElena Soriano
Elena Soriano
Dimitra Hadjipavlou-LitinaDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
AAAlberto Alcázar
Alberto Alcázar
Abdelouahid SamadiAbdelouahid Samadi
Abdelouahid Samadi

1 August 2012 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EMEmna Maalej
Emna Maalej
FCFakher Chabchoub
Fakher Chabchoub
María Jesús Oset-GasqueMaría Jesús Oset-Gasque
María Jesús Oset-Gasque
MEMario Esquivias-Pérez
Mario Esquivias-Pérez
MGMaría P. González
María P. González
Abdelouahid SamadiAbdelouahid Samadi
Abdelouahid Samadi

1 September 2013 in Current Alzheimer Research
Verified
Journal Article
Closed access
IBIrene Bolea
Irene Bolea
AGAlejandro Gella
Alejandro Gella
LMLeticia Monjas
Leticia Monjas
CPConcepción Pérez
Concepción Pérez
MRMaría Isabel Rodríguez-Franco
María Isabel Rodríguez-Franco
MUMercedes Unzeta
Mercedes Unzeta
Amyloid beta (Aβ) aggregation and deposition is a key pathological hallmark of AD. Growing evidence suggests that neurotoxicity of this peptide is related to the formation of toxic oligomeric aggregates. Therefore, a deeply investigated therapeutic strategy comes at present from blocking the formation of these species to non-toxic aggregates. Among other considered strategies, the multi-target approach has been proposed as a more suitable potential therapy, precisely due to the multifactorial nature of AD. In this context, we recently identified ASS234, a novel compound that possesses a significant multipotent profile since it is able to inhibit cholinesterase and monoamine oxidase enzymes as well as to interfere in Aβ aggregation process. In this work, we investigated more in detail the effects of ASS234 on Aβ aggregation and toxicity in vitro as well as we explored its ability to penetrate to the CNS. We report that ASS234 inhibited Aβ1-42 self-aggregation more efficiently than that of Aβ1-40, limiting the formation of fibrillar and oligomeric species. Additionally, ASS234 completely blocked the aggregation mediated by AChE of both Aβ1-42 and Aβ1-40, showing a dual binding site to AChE. Interestingly, ASS234 significantly reduced Aβ1-42-mediated toxicity in SH-SY5Y human neuroblastoma cells through the prevention of the mitochondrial apoptosis pathway activation. Also importantly, we observed a significant ability of ASS234 to capture free-radical species in vitro as well as a potent effect in preventing the Aβ1-42-induced depletion of antioxidant enzymes (catalase and SOD-1). Finally, we report the capability of ASS234 to cross the bloodbrain barrier. Overall, our in vitro results show that ASS234 may have an impact on different processes involved in AD pathogenesis and provide evidences that it has encouraging attributes as a therapeutic lead compound.

30 April 2019 in The Journal of Physical Chemistry C
Verified
Journal Article
Open access
JLJun Li
Jun Li
LSLeonid Solianyk
Leonid Solianyk
NSNico Schmidt
Nico Schmidt
BBBrian Baker
Brian Baker
SGStefano Gottardi
Stefano Gottardi
MSMeike Stöhr
Meike Stöhr
We report the formation of one- and two-dimensional metal-organic coordination structures from para-hexaphenyl-dicarbonitrile (NC-Ph6-CN) molecules and Cu atoms on graphene epitaxially grown on Ir(111). By varying the stoichiometry between the NC-Ph6-CN molecules and Cu atoms, the dimensionality of the metal-organic coordination structures could be tuned: for a 3:2 ratio, a two-dimensional hexagonal porous network based on three-fold Cu-coordination was observed, while for a 1:1 ratio, one-dimensional chains based on two-fold Cu-coordination were formed. The formation of metal-ligand bonds was supported by imaging the individual Cu atoms within the metal-organic coordination structures with scanning tunneling microscopy. Scanning tunneling spectroscopy measurements demonstrated that the electronic properties of NC-Ph6-CN molecules and Cu atoms were different between the two-dimensional porous network and the one-dimensional molecular chains.

26 March 2012 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
LGLaura González-Lafuente
Laura González-Lafuente
Javier EgeaJavier Egea
Javier Egea
Rafael LeónRafael León
Rafael León
FMFrancisco J. Martínez-Sanz
Francisco J. Martínez-Sanz
LMLeticia Monjas
Leticia Monjas
Cristobal De Los RiosCristobal De Los Rios
Cristobal De Los Rios